Development of regenerative biologic matrices
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
173
NCT05681182
Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone
Phase: Phase 4
Role: Collaborator
Start: Jan 20, 2023
Completion: Feb 6, 2024
NCT06063538
Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone
Phase: Early Phase 1
Start: Feb 15, 2024
Completion: Jun 30, 2027
NCT06730828
Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 16, 2024
Completion: May 31, 2026
Loading map...